Pettersson Anna, Nygren Peter, Persson Christina, Berglund Anders, Turesson Ingela, Johansson Birgitta
Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden.
Pfizer AB, Sollentuna, Sweden.
Radiother Oncol. 2014 Nov;113(2):240-7. doi: 10.1016/j.radonc.2014.11.025. Epub 2014 Nov 29.
To evaluate the long-term effects of dietary intervention on gastrointestinal symptoms after highly dose-escalated radiotherapy for localized prostate cancer, using boost with protons or high-dose-rate brachytherapy.
Patients were randomized to an intervention group (n=64) advised to reduce insoluble dietary fiber and lactose intake, or to a standard care group (n=66) advised to continue their usual diet. Gastrointestinal symptoms, other domains of health-related quality of life (HRQOL), and dietary intake were evaluated for ⩽24months post-radiotherapy with the European Organization for Research and Treatment of Cancer quality-of-life questionnaires QLQ-C30 and QLQ-PR25, Gastrointestinal Side Effects Questionnaire, and Food Frequency Questionnaire. The effect of the intervention on gastrointestinal symptoms was evaluated using generalized estimating equations.
Dietary intervention had no obvious effect on long-term gastrointestinal symptoms or HRQOL. The intervention group markedly reduced their dietary fiber and lactose intake during radiotherapy, but adherence tended to decline over time. The vast majority of long-term gastrointestinal symptoms were reported as 'a little', with a noticeable difference from pre-treatment only for unintentional stool leakage, limitations on daily activities, and mucus discharge.
Long-term gastrointestinal symptoms were predominantly mild, and dietary intervention was not superior to a usual diet in preventing these symptoms.
采用质子增敏或高剂量率近距离放射治疗对局限性前列腺癌进行高剂量递增放疗后,评估饮食干预对胃肠道症状的长期影响。
将患者随机分为干预组(n = 64),建议减少不溶性膳食纤维和乳糖摄入,或标准护理组(n = 66),建议继续其常规饮食。放疗后⩽24个月,使用欧洲癌症研究与治疗组织生活质量问卷QLQ - C30和QLQ - PR25、胃肠道副作用问卷和食物频率问卷评估胃肠道症状、健康相关生活质量(HRQOL)的其他领域以及饮食摄入量。使用广义估计方程评估干预对胃肠道症状的影响。
饮食干预对长期胃肠道症状或HRQOL无明显影响。干预组在放疗期间显著减少了膳食纤维和乳糖摄入,但依从性随时间推移有下降趋势。绝大多数长期胃肠道症状报告为“轻微”,仅无意性大便失禁、日常活动受限和黏液排出与治疗前有明显差异。
长期胃肠道症状主要为轻度,饮食干预在预防这些症状方面并不优于常规饮食。